Birth Defects
0
Pipeline Programs
11
Companies
5
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Peptide
1100%
+ 12 programs with unclassified modality
Competitive Landscape
11 companies ranked by most advanced pipeline stage
Syneos HealthNC - Morrisville
3 programsBetaseron Pregnancy RegistryN/A1 trial
The Ribavirin Pregnancy RegistryN/A
Uterine Fibroid Pregnancy RegistryN/A1 trial
Active Trials
AstraZenecaCAMBRIDGE, United Kingdom
1 programExenatide Pregnancy Registry - Type 2 Diabetes in PregnancyN/APeptide1 trial
Active Trials
UCB PharmaBelgium - Brussels
1 programUCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry)N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AstraZenecaExenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy
Syneos HealthBetaseron Pregnancy Registry
Syneos HealthUterine Fibroid Pregnancy Registry
UCB PharmaUCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry)
SandozThe Ribavirin Pregnancy Registry
Clinical Trials (5)
Total enrollment: 3,473 patients across 5 trials
Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy
Start: Jan 2009Est. completion: Apr 20167 patients
N/ATerminated
Betaseron Pregnancy Registry
Start: Apr 2006Est. completion: Jun 2012113 patients
N/ACompleted
Uterine Fibroid Pregnancy Registry
Start: Dec 2005Est. completion: Dec 20052,360 patients
N/ATerminated
NCT00345475UCB PharmaUCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry)
UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry)
Start: Dec 2004Est. completion: May 2016516 patients
N/ACompleted
The Ribavirin Pregnancy Registry
Start: Jan 2004Est. completion: Nov 2020477 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
11 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.